SCHEMBL13764510

SCHEMBL13764510

O=C(CCc1ccc(CCc2coc3cccc(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c23)cc1)NC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO

nearest known ligand 0.47

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ SLC5A1 P13866 14/20 0.47
▸ SLC5A2 P31639 14/20 0.47
▸ CD22 P20273 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13764506 0.95 SLC5A2 (0.46) SLC5A1SLC5A2
SCHEMBL13764504 0.91 SLC5A1 (0.45) SLC5A1SLC5A2
SCHEMBL13764505 0.85 SLC5A1 (0.48) SLC5A1SLC5A2
SCHEMBL1726679 0.80 SLC5A2 (0.54) SLC5A1SLC5A2
SCHEMBL1728349 0.80 SLC5A2 (0.50) SLC5A1SLC5A2
SCHEMBL1728750 0.80 SLC5A1 (0.51) SLC5A1SLC5A2
SCHEMBL1728624 0.80 SLC5A2 (0.51) SLC5A1SLC5A2HSD17B10KDM4ECYP3A4
SCHEMBL1728251 0.79 SLC5A2 (0.55) SLC5A1SLC5A2
SCHEMBL1726677 0.79 SLC5A1 (0.56) SLC5A1SLC5A2HSD17B10KDM4ECYP3A4
SCHEMBL1726690 0.79 SLC5A2 (0.56) SLC5A1SLC5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7566699-B2 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-07-28 — — US disclosed
US-7566699-B2 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-07-28 — — US disclosed
Send feedback